OxyContin maker will stop promoting opioids to doctors
FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Less than three months after President Donald Trump declared the U.S. opioid crisis a public health emergency in October 2017, the nation's governors are calling on his administration and Congress to provide more money and coordination for the fight against the drugs. (AP Photo/Toby Talbot, File)
New York • The maker of the powerful painkiller OxyContin said it will stop marketing opioid drugs to doctors, a surprise reversal following lawsuits that blamed the company for helping trigger the current drug abuse epidemic.
OxyContin has long been the world’s top-selling opioid painkiller. It generated billions in sales for privately-held Purdue.
The pill, a time-release version of oxycodone, was hailed as a breakthrough treatment for chronic pain when it was approved in late 1995. But some users quickly discovered they could get a heroin-like high by crushing the pills and snorting or injecting the entire dose at once.
Purdue’s promotions exaggerated the drug’s safety and risks of addiction, leading to lawsuits and federal investigations. But the drug continued to rack up blockbuster sales.
sltrib.com is now free to access — no subscription required. We made this decision because we believe access to trustworthy, independent news shouldn’t depend on what you can afford — especially as misinformation and AI-generated content continue to rise.
Free to read doesn’t mean free to produce. Our reporters show up every day to ask hard questions and hold powerful institutions to account. That work takes resources. As a nonprofit newsroom, we rely on support from people who believe it matters. Make a donation today to fund local news that serves Utah communities.
You can help us bring more local news to more communities today.